Potential Involvement of NHE1 in COVID-19 Related Pulmonary Damage

被引:0
|
作者
Ta, Lam
Vigilante, Danielle
Iyer, Meera
Provost, Joseph
机构
[1] Chemistry and Biochemistry, University of San Diego, San Diego
来源
FASEB JOURNAL | 2022年 / 36卷
关键词
D O I
10.1096/fasebj.2022.36.S1.R5153
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In some moderate and severe COVID-19 infections lung scarring similar to fibrosis have been observed in survivors, many of which have persistent functional and radiographic abnormalities at the initial follow-up suggesting a possible shared pathobiology between fibrotic lung disease and COVID-19- lung disease. Fibrosis is an inflammatory response to pulmonary infections that activates fibroblasts and produces excessive extracellular matrix proteins that stiffen cells, leading to reduction in lung capacity and breathing deficiency. Several factors involved in the "cytokine storm" also are pre-fibrotic leading to the advanced disease. This includes interleukin 6 and others. The focus of this study is on sodium hydrogen exchanger isoform 1 (NHE1) that plays a key role in intracellular pH regulation and cell movement and its effect on fibrosis development. Both cytokines IL-1 and IL-6 are used to show one measure of cell restructuring and stiffness by measuring stress fiber formation. To examine the role of NHE1 in fibroblast response, both IL-1 and IL-6 cells were treated with proinflammatory cytokines in the presence and absence of NHE1 inhibitor (EIPA). This study will provide an initial insight to the relationship between NHE1 and proinflammatory response for future experiments. © FASEB.
引用
收藏
页数:1
相关论文
共 50 条
  • [41] COVID-19 with Pulmonary Involvement. An Autoimmune Disease of Known Cause
    Fernandez-Gutierrez, Benjamin
    REUMATOLOGIA CLINICA, 2020, 16 (04): : 253 - 254
  • [42] Potential of Immune-Related Therapy in COVID-19
    Yuan, Chunjue
    Li, Ruoyun
    Liu, Guohong
    Pan, Yunbao
    FRONTIERS IN PHARMACOLOGY, 2021, 11
  • [43] Cardiac Involvement in COVID-19
    Sugraliyev, A. B.
    KARDIOLOGIYA, 2021, 61 (04) : 15 - 23
  • [44] ANALYSIS OF BENEFITS AND POTENTIAL DAMAGE FROM COVID-19 VACCINATION
    Park, Y.
    Cho, Y. K.
    Jung, J.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2023, 130 : S58 - S58
  • [45] Gut Involvement by COVID-19
    Khanna, Sahil
    MAYO CLINIC PROCEEDINGS, 2020, 95 (11) : 2309 - 2311
  • [46] COVID-19 and lung involvement
    Dezzani, Elena O.
    GAZZETTA MEDICA ITALIANA ARCHIVIO PER LE SCIENZE MEDICHE, 2023, 182 (09) : 487 - 496
  • [47] Kidney involvement in COVID-19
    Allison S.
    Nature Reviews Nephrology, 2021, 17 (9) : 572 - 572
  • [48] Pulmonary fibrosis and COVID-19: the potential role for antifibrotic therapy
    George, Peter M.
    Wells, Athol U.
    Jenkins, R. Gisli
    LANCET RESPIRATORY MEDICINE, 2020, 8 (08): : 807 - 815
  • [49] Pulmonary Edema in COVID-19 Patients: Mechanisms and Treatment Potential
    Cui, Xinyu
    Chen, Wuyue
    Zhou, Haoyan
    Gong, Yuan
    Zhu, Bowen
    Lv, Xiang
    Guo, Hongbo
    Duan, Jinao
    Zhou, Jing
    Marcon, Edyta
    Ma, Hongyue
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [50] Potential Interactions of Remdesivir with Pulmonary Drugs: a Covid-19 Perspective
    Zainab Gandhi
    Zeeshan Mansuri
    Snehal Bansod
    SN Comprehensive Clinical Medicine, 2020, 2 (10) : 1707 - 1708